Impilo, a leading Nordic investment firm exclusively focused on the healthcare sector, has acquired Oticon Medical from Demant, the Danish-based global leader in hearing healthcare, listed on Nasdaq Copenhagen.
Oticon Medical is a global company specialising in bone-anchored hearing solutions (BAHS), enhancing the hearing experience for people at every stage of life. Renowned for its innovative approach, the company collaborates closely with leading audiologists, surgeons, and other hearing specialists.
Founded in 2017, Impilo manages EUR 2bn on behalf of prominent Nordic and international investors. The firm is guided by a philosophy centered on making meaningful contributions to the societies, markets and patients it serves.
The acquisition marks a significant milestone for Impilo, strengthening its long-term growth strategy and providing a solid platform for future success. Impilo will work closely with Demant while investing in and accelerating the development of next-generation BAHS solutions.
Accura advised Impilo in connection with the transaction.